reboxetine has been researched along with oxidopamine in 2 studies
Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) | Studies (oxidopamine) | Trials (oxidopamine) | Recent Studies (post-2010) (oxidopamine) |
---|---|---|---|---|---|
626 | 193 | 184 | 8,630 | 6 | 2,407 |
Protein | Taxonomy | reboxetine (IC50) | oxidopamine (IC50) |
---|---|---|---|
Glyceraldehyde-3-phosphate dehydrogenase | Homo sapiens (human) | 8 | |
DNA repair protein RAD52 homolog | Homo sapiens (human) | 0.779 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cryan, JF; Lucki, I; Page, ME | 1 |
Di Chiara, G; Frau, R; Valentini, V | 1 |
2 other study(ies) available for reboxetine and oxidopamine
Article | Year |
---|---|
Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Benzylamines; Dose-Response Relationship, Drug; Frontal Lobe; Hypothalamus; Locus Coeruleus; Male; Morpholines; Neurotoxins; Norepinephrine; Oxidopamine; Rats; Rats, Sprague-Dawley; Reboxetine; Swimming; Sympatholytics; Tegmentum Mesencephali | 2002 |
Noradrenaline transporter blockers raise extracellular dopamine in medial prefrontal but not parietal and occipital cortex: differences with mianserin and clozapine.
Topics: Analysis of Variance; Animals; Cerebral Cortex; Clozapine; Desipramine; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Interactions; Extracellular Space; Male; Mianserin; Microdialysis; Morpholines; Neural Pathways; Norepinephrine Plasma Membrane Transport Proteins; Oxidopamine; Piperazines; Rats; Rats, Sprague-Dawley; Reboxetine; Serotonin Antagonists; Symporters; Time Factors | 2004 |